Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 07/10/2024, with an aggregate market value of $108,575.69. The shares were acquired through stock option exercises on 06/13/2023 and 06/14/2023, with a total of 15,000 shares obtained from the issuer for a cash payment. This planned sale follows a series of transactions over the past three months, where a total of 93,124 shares were sold for gross proceeds of approximately $755,664.65.

Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 07/10/2024, with an aggregate market value of $108,575.69. The shares were acquired through stock option exercises on 06/13/2023 and 06/14/2023, with a total of 15,000 shares obtained from the issuer for a cash payment. This planned sale follows a series of transactions over the past three months, where a total of 93,124 shares were sold for gross proceeds of approximately $755,664.65.